Cocaine use among heroin users in Spain: the diffusion of crack and cocaine smoking. Spanish Group for the Study on the Route of Administration of Drugs-Reference-Cited by-同舟云学术

Cocaine use among heroin users in Spain: the diffusion of crack and cocaine smoking. Spanish Group for the Study on the Route of Administration of Drugs

Published:1998-03-01 Issue:3 Volume:52 Page:172-180
ISSN:0143-005X
Container-title:Journal of Epidemiology & Community Health
language:en
Short-container-title:Journal of Epidemiology & Community Health

Author:

Barrio G.,De la Fuente L.,Royuela L.,Diaz A.,Rodriguez-Artalejo F.

Publisher

BMJ

Subject

Public Health, Environmental and Occupational Health,Epidemiology

Reference41 articles.

1. From chasing the dragon to chinezen. The diVusion of heroin smoking in the;Grund, J.P.; Blanken, P.,1993

2. on Drug Abuse -NIDA-. Epidemiologic trends in drug abuse. Community Epidemiology Work Group;National Institute,1995

3. Crack use and injection on the increase among injecting drug users in London;Hunter, G.M.; Donoghoe, M.C.; Stimson, G.V.;Addiction,1995

4. New patterns of cocaine use: changing doses and routes;Siegel, R.K.;NIDA Research Monograph Series; use in America: epidemiological and clinical perspectives,1985

5. Cocaine and other stimulants;Gawin, F.H.; Ellinwood, E.H.;N Engl J Med,1988

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Correlates of Stimulant Use among People Who Use Heroin Undergoing Treatment in Out-Patient Facilities in France, 2010–2020;Substance Use & Misuse;2023-10-19

2. Transition from injecting opioids to smoking fentanyl in San Francisco, California;Drug and Alcohol Dependence;2021-10

3. Ammonia poisoning in drug users, is there an emerging problem?;Toxicologie Analytique et Clinique;2021-09

4. The phenomics and genetics of addictive and affective comorbidity in opioid use disorder;Drug and Alcohol Dependence;2021-04

5. Estimating the size of crack cocaine users in France: Methods for an elusive population with high heterogeneity;International Journal of Drug Policy;2020-02